[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342704-105":59,"doc-detail-342704-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mettl3-mediated-rangap1-promotes-colorectal-cancer-progression-through-the-mapk-pathway-by-recruiting-ythdf1-article","METTL3-mediated RanGAP1 promotes colorectal cancer progression through the MAPK pathway by recruiting YTHDF1 - Article","","RanGAP1 is implicated in multiple diseases, yet its function in colorectal cancer (CRC) progression has remained unclear. Analysis of tumor tissues and public databases shows RanGAP1 is significantly upregulated in CRC and correlates with poor patient prognosis. METTL3-driven N6-methyladenosine (m6A) modification of RanGAP1 and YTHDF1 recruitment underlie the mechanism, supported by MeRIP-seq, RIP-qPCR, luciferase reporter assays, RNA-seq, and functional cell and xenograft experiments. Results indicate RanGAP1 influences CRC progression via the MAPK signaling pathway, suggesting biomarker and therapeutic target potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mettl3-mediated-rangap1-promotes-colorectal-cancer-progression-through-the-mapk-pathway-by-recruiting-ythdf1-article/342704/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mettl3-mediated-rangap1-promotes-colorectal-cancer-progression-through-the-mapk-pathway-by-recruiting-ythdf1-article/342704.png","ImageObject",300,407,{"name":92,"@type":93},"Ava Thompson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main finding about RanGAP1 in colorectal cancer?","Question",{"text":112,"@type":113},"RanGAP1 is significantly upregulated in colorectal cancer tissues, and higher expression is associated with poor patient prognosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do METTL3, m6A, and YTHDF1 relate to RanGAP1?",{"text":117,"@type":113},"METTL3 mediates N6-methyladenosine modification of RanGAP1, and YTHDF1 recruitment helps drive the regulatory effects on RanGAP1 expression.",{"name":119,"@type":110,"acceptedAnswer":120},"Which signaling pathway is involved in CRC progression according to the study?",{"text":121,"@type":113},"The study links RanGAP1-driven effects on CRC progression to the Mitogen-Activated Protein Kinase (MAPK) signaling pathway.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342704,1790106835,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","[www.nature.com/cgt](www.nature.com/cgt) Cancer Gene Therapy  \nARTICLE OPEN   \nMETTL3-mediated RanGAP1 promotes colorectal cancer  \nprogression through the MAPK pathway by recruiting YTHDF1  \nRui Yang 1,3, Cheng Yang 1,3, Danjie Su2,3, Yang Song1, Jie Min 1, Zhixin Qian 1, Xiangjing Shen 1, Junqiang Li1 ✉ and Haichuan Su 1 ✉  \n© The Author(s) 2024  \n\n|  |  |  |\n| --- | --- | --- |\n|  | Ran GTPase activating protein 1 (RanGAP1) has been implicated in various diseases, but its role in colorectal cancer (CRC) progression remains unclear. Using tumor tissues and public databases, we found that RanGAP1 was signiﬁcantly upregulated in CRC tissues and was associated with poor prognosis of patients. N6-methyladenosine (m6A) was found to play an important role in higher expression of RanGAP1 . MeRIP-seq, RIP-qPCR, Luciferase reporter assays and other related experiment elucidated the molecular mechanism underlying m6A modiﬁcation of RanGAP1 . Besides, cell function experiments and xenograft tumor models corroborated the function of RanGAP1 in CRC progression. By RNA-seq and related analysis, RanGAP1 was veriﬁed to inﬂuent CRC progression via the Mitogen-Activated Protein Kinase (MAPK) signaling pathway. Therefore, N6-methyladenosine modiﬁcation of RanGAP1 by METTL3/YTHDF1 plays a role in CRC progression through the MAPK pathway and could be a potential biomarker and therapeutic target for CRC.\u003Cbr>Cancer Gene Therapy (2024) 31:562–573; [https://doi.org/10.1038/s41417-024-00731-5](https://doi.org/10.1038/s41417-024-00731-5) |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n\nGraphical Abstract  \nSchematic diagram showed that N6-methyladenosine modiﬁcation of RanGAP1 promotes CRC progression via the MAPK signaling pathway.  \nINTRODUCTION  \nOver the past ﬁve years, colorectal cancer is still the third most common cancer worldwide, causing an extremely high death rate [1] . Due to the recent vigorous development of colonoscopy and other procedures, the prevention, diagnosis, and treatment of colorectal cancer have signiﬁcantly progressed. However, because of its rapid proliferation and frequent metastasis, the prognosis of patients is still less than satisfactory [2] . Hence, it’s extremely important to further explore the molecular mechanism of CRC to improve treatment strategies.  \nRanGAP1 is the GTPase activating protein of the small GTPase Ran, which is primarily localized in the cytoplasm [3] . The RanGAP1-SUMO1 protein is localized in the nuclear membrane and functions as a component of the cytoplasmic ﬁlaments within the nuclear pore complex (NPC), regulating nuclear transport [4, 5] . Additionally, the RanGAP1/RanBP2 complex plays a crucial role in ensuring stable kinetochore-microtubule association [6] . In osteosarcoma, the loss of RanGAP1 leads to chromosomal instability and rapid tumorigenesis [7] . Nevertheless, the expression level and the role of RanGAP1 in CRC remain ambiguous.  \n1Department of Oncology, Tangdu Hospital, Air Force Medical University, Xi’an 710038 Shaanxi, China. 2Department of Obstetrics and Gynecology, Tangdu Hospital, Air Force Medical University, Xi’an 710038 Shaanxi, China. 3These authors contributed equally: Rui Yang, Cheng Yang, Danjie Su. ✉ email: [jjunqiang@126.com](jjunqiang@126.com); [suhc@fmmu.edu.cn](suhc@fmmu.edu.cn)  \nReceived: 13 August 2023 Revised: 6 January 2024 Accepted: 9 January 2024  \nPublished online: 24 January 2024  \nN6-methyladenosine is currently considered as one of the most common forms of transcript modiﬁcation in eukaryotes. The m6A methyltransferase METTL3 (a writer) and the speciﬁc RNA binding protein YTHDF1 (a reader) can directly or indirectly identify and bind speciﬁc m6A motifs to regulate mRNA stability or protein translation [8] . Previous studies have shown that METTL3 and YTHDF1 are involved in CRC progression. However, their biological signiﬁcance and potential regulatory mechanism remain uncl","cbCait42wL2pYiH6","https://ap.wps.com/l/cbCait42wL2pYiH6","pdf",8903183,12,"English","# Introduction\n# Materials and Methods\n## Colorectal cancer patient samples\n## Cell culture and lentivirus infection","[{\"question\":\"What is the main finding about RanGAP1 in colorectal cancer?\",\"answer\":\"RanGAP1 is significantly upregulated in colorectal cancer tissues, and higher expression is associated with poor patient prognosis.\"},{\"question\":\"How do METTL3, m6A, and YTHDF1 relate to RanGAP1?\",\"answer\":\"METTL3 mediates N6-methyladenosine modification of RanGAP1, and YTHDF1 recruitment helps drive the regulatory effects on RanGAP1 expression.\"},{\"question\":\"Which signaling pathway is involved in CRC progression according to the study?\",\"answer\":\"The study links RanGAP1-driven effects on CRC progression to the Mitogen-Activated Protein Kinase (MAPK) signaling pathway.\"}]","METTL3-mediated RanGAP1 promotes colorectal cancer progression through the MAPK pathway by recruiting YTHDF1 - Article | PDF",1790047785,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d2446df18a28510ad794ab9328eedcf.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d049eb884698aae6aa39983fc8b3d65.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/563647673682c17cd3bb3f39f2b96db9.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3ea154930e4b015af41ac8d51219aa7.webp",980,1301]